Pursuant to section 1004.4351, Florida Statutes, the Medical Marijuana Research and Education Board is established to direct the operations of the Coalition. The Board shall be composed of seven members appointed by the chief executive officer of the H. Lee Moffitt Cancer Center and Research Institute, Inc. Board members must have experience in a variety of scientific and medical fields, including, but not limited to, oncology, neurology, psychology, pediatrics, nutrition, and addiction. Members shall be appointed to 4-year terms and may be reappointed to serve additional terms. The chair shall be elected by the Board from among its members to serve a 2-year term. The Coalition shall be administered by a Coalition Director, who shall be appointed by and serve at the pleasure of the Board.

The seven Medical Marijuana Research and Education Board members were appointed by Alan F. List, M.D., President and CEO of the Moffitt Cancer Center, on August 18, 2017. On October 30, 2017, the Board appointed Nagi B. Kumar, Ph.D., R.D., FADA as the Coalition Director. 

 

Coalition Director

Nagi B. Kumar, Ph.D., R.D., FADA

Moffitt Cancer Center

Director, Cancer Chemoprevention; Senior Member, Divisions of Population Sciences & Genitourinary Oncology

Board Members

Chair, Thomas Sellers, Ph.D., MPH

Moffitt Cancer Center  

Center Director & Executive Vice President

Vice Chair, Almut Winterstein, Ph.D.

University of Florida      

Professor & Chair, Pharmaceutical Outcomes & Policy         

Thomas Brandon, Ph.D.

Moffitt Cancer Center  

Clinical psychologist; Chair, Health Outcomes & Behavior; Director, Tobacco Research & Intervention Program   

Jennifer Keehbauch, M.D., FAAFP

Winter Park Memorial Hospital

Chief Medical Officer & Vice President

Leonard Rappa, Pharm.D., BCPP

Florida A&M University

Professor, Pharmacy Practice, Psychiatry

 

Sabita Roy, Ph.D.

University of Miami       

Professor of Surgery

Laufey Yr Sigurdardottir, M.D.

Nemours Children's Hospital      

Pediatric Neurologist